Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2026-03-24 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2025年年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised by Shenzhen Huitai Medical Device Co., Ltd. in 2025. It includes specifics on the amount of funds raised, their allocation, usage, management policies, investment projects, changes in project funding, and compliance with regulatory requirements. It also contains audit opinions and sponsor verification related to the use of raised funds. The document is titled as a "专项报告" (special report) on the storage and actual use of raised funds for the year 2025. This type of report is a specialized disclosure related to capital raised through public offerings and its usage, which aligns with the category of Capital/Financing Update (CAP). It is not a full annual report, audit report, or earnings release, but a focused report on fundraising and capital usage. The length and detail confirm it is the report itself, not just an announcement of a report publication.
2026-03-24 Chinese
2025年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2025年度董事会审计委员会履职情况报告" which translates to "2025 Board Audit Committee Performance Report." It details the audit committee's activities, including oversight of external and internal audits, review of financial reports, internal control evaluation, and coordination with auditors. It references various financial reports (annual, semi-annual, quarterly) and audit evaluations but does not contain the actual financial statements or detailed financial data itself. The document is a report on the audit committee's duties and performance rather than a full audit report or annual report. Given the focus on audit committee activities and evaluation of audit work, this fits best under the category of Audit Report / Information (AR). The document length is 3361 characters, which is relatively short but contains substantive content about audit committee work, not just an announcement or certification. Therefore, it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). FY 2025
2026-03-24 Chinese
2026年限制性股票激励计划（草案）
Remuneration Information Classification · 95% confidence The document is a detailed draft of a 2026 restricted stock incentive plan by Shenzhen Huitai Medical Device Co., Ltd. It includes comprehensive information about the stock incentive plan, including legal basis, stock source, number of shares, grant price, vesting conditions, management structure, and performance targets. The document is lengthy (15,000 characters) and contains substantive content about the company's management and compensation plans related to stock incentives. It is not a simple announcement or a brief summary but a full plan draft. This type of document fits best under the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors, including stock incentive plans.
2026-03-24 Chinese
2025年度独立董事述职报告（李光）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2025 for Shenzhen Huitai Medical Devices Co., Ltd. It details the independent director's background, attendance at board and committee meetings, exercise of duties, communication with auditors, and opinions on company governance and financial reporting. It does not contain financial statements or detailed financial data but rather focuses on the director's activities and governance oversight during the year. This type of document is a report by an independent director on their duties and observations, which fits the category of Board/Management Information (MANG). The document length is 4310 characters, which is consistent with a detailed report but not a full annual report or audit report. There is no indication that this is a regulatory filing, announcement, or other category. Therefore, the best classification is MANG with high confidence.
2026-03-24 Chinese
2025年度独立董事述职报告（孙乐非）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 from Shenzhen Huitai Medical Devices Co., Ltd. It details the independent director's duties, attendance at board and committee meetings, oversight of financial reports, audit committee activities, and governance matters throughout the year. The content focuses on the independent director's role, supervision, and evaluation of company governance and financial reporting, rather than presenting the company's full financial statements or comprehensive annual performance report. This type of document is a report by a board member on their management and governance activities, which fits the category of Board/Management Information (MANG). It is not an Annual Report (10-K) or Audit Report (AR) because it does not contain full financial statements or audit opinions. It is also not a Regulatory Filing or Report Publication Announcement as it contains substantive content rather than just an announcement. Therefore, the appropriate classification is MANG with high confidence.
2026-03-24 Chinese
董事会对独立董事2025年度独立性自查情况的专项报告
Board/Management Information Classification · 95% confidence The document is a special report from the board of directors assessing the independence of the company's independent directors for the year 2025. It references regulatory guidelines related to independent directors and confirms their compliance with independence requirements. The content focuses on governance and board management matters rather than financial results or other report types. The document length is short and it is a specific report on board/management information regarding director independence. Therefore, the most appropriate classification is Board/Management Information (MANG).
2026-03-24 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.